Functional characterization of infiltrating T lymphocytes in human hepatic allografts

scientific article

Functional characterization of infiltrating T lymphocytes in human hepatic allografts is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0198-8859(86)90047-9
P932PMC publication ID3005262
P698PubMed publication ID3087922
P5875ResearchGate publication ID223941616

P50authorThomas E. StarzlQ1248240
John Julian FungQ61476062
Adriana ZeeviQ64123938
Anthony J. DemetrisQ64148695
P2093author name stringS Iwatsuki
R J Duquesnoy
P2860cites workFurther characterization of HLA-DS molecules: implications for studies assessing the role of human Ia molecules in cell interactions and disease susceptibilityQ24594330
Liver transplantation against T cell-positive warm crossmatchesQ33757385
Current Status of Hepatic TransplantationQ34207236
Five-Year Survival After Liver TransplantationQ34396534
Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimenQ35834932
Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytesQ36335723
Tissue-specific and tissue-restricted histocompatibility antigensQ38257614
Monoclonal antibodies for analysis of the HLA systemQ39594265
Partial characterization of cytotoxic cells infiltrating sponge matrix allograftsQ39884046
Analysis of Intragraft Effector Mechanisms Associated with Human Renal Allograft Rejection: Immunohistological Studies with Monoclonal AntibodiesQ40116973
Interactions of T lymphocytes with human vascular endothelial cells: role of endothelial cells surface antigens.Q40201690
Mechanism of T cell activation: role and functional relationship of HLA-DR antigens and interleukinsQ40264396
The role of T8 in the cytotoxic activity of cloned cytotoxic T lymphocyte lines specific for class II and class I major histocompatibility complex antigensQ41279380
Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activationQ41570220
Induction of DR/IA antigens in human liver allografts. An immunocytochemical and clinicopathologic analysis of twenty failed graftsQ42074087
Two populations of Ia-like molecules on a human B cell line.Q42800259
A matrix approach to human class II histocompatibility antigens: Reactions of four monoclonal antibodies with the products of nine haplotypesQ44355770
Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants.Q52850793
Direct evidence of homology between human DC-1 antigen and murine I-A molecules.Q53679030
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection.Q55475721
Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejectionQ67273987
Effector mechanisms in allograft rejection. I. Assembly of "sponge matrix" allograftsQ67831563
The lymphocyte subpopulations in cyclosporine-treated human heart rejectionQ69935253
The vascular endothelial cell antigen systemQ69939809
Specificity of alloactivated human T lymphocyte clones in secondary proliferation, cell-mediated lympholysis and interleukin-2 releaseQ69975011
Expression of HLA-DR on T lymphocytes following renal transplantation, and association with graft-rejection episodes and cytomegalovirus infectionQ70188436
T lymphocyte monitoring in kidney transplant recipients undergoing cytomegalovirus infection or rejection episodesQ70199608
OKT4+ cytotoxic T cells can lyse targets via class I molecules and can be blocked by monoclonal antibody against T4 moleculesQ70223540
Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patientsQ70286856
Clonal analysis of the lymphoid cells mediating skin allograft rejection. Mediation of graft rejection in vivo by cloned Lyt-1+2- proliferative, noncytotoxic long-term cell linesQ70296962
Lymphocyte enumeration: a comparison between a modified avidin-biotin-immunoperoxidase system and flow cytometryQ70332976
Clinical significance of in situ detection of T lymphocyte subsets and monocyte/macrophage lineages in heart allograftsQ70399257
Relationships among the histologic pattern, intensity, and phenotypes of T cells infiltrating renal allograftsQ70399285
Renal allograft infiltrate in the absence of rejectionQ70399373
Characterization of mononuclear cell infiltrates in human cardiac allograftsQ70399387
Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejectionQ72401831
Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinantsQ72681432
Detection of non-HLA-DR determinants by alloreactive lymphocyte clonesQ72692537
Alterations in T lymphocyte subpopulations associated with renal allograft rejectionQ72809014
Mechanisms of Rejection and Prolongation of Vascularized Organ AllograftsQ72812686
P433issue2
P304page(s)182-199
P577publication date1986-06-01
P1433published inHuman ImmunologyQ15709955
P1476titleFunctional characterization of infiltrating T lymphocytes in human hepatic allografts
P478volume16

Reverse relations

cites work (P2860)
Q34207045A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors
Q38515793A quantitative analysis of T lymphocyte populations in human liver allografts undergoing rejection: the use of monoclonal antibodies and double immunolabeling
Q34396506ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGS
Q28659287Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation
Q34219286Allospecificity of liver allograft-derived lymphocytes and correlation with clinicopathologic findings
Q71173497Altered patterns of migration of cytokine-producing T lymphocytes in skin-grafted naive or immune mice following in vivo administration of anti-VCAM-1 or -ICAM-1
Q79420997Analysis of KIR2D receptors on peripheral blood lymphocytes from liver graft recipients
Q33997708Analysis of T lymphocytes infiltrating human hepatic allografts
Q73336587Analysis of post-transplant immune status in recipients of liver/bone marrow allografts
Q41109764Association of HLA Compatibility and Decreased Liver Transplant Survival
Q68902072Dynamics of allospecific T lymphocyte infiltration in vascularized human allografts
Q72092802Establishment and immunological characterization of cultured human gallbladder epithelial cells
Q42732038Establishment of Primary Cultures of Human Biliary Epithelium and Induction of Class II Major Histocompatibility Complex Antigens by Interferon Gamma.
Q34396773Functional characteristics of lymphocytes propagated from a human multivisceral allograft.
Q41912589HLA histocompatibility and liver transplant survival
Q34206976Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect?
Q73083437Human leukocyte antigen-C in short- and long-term liver graft acceptance
Q34942525IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION.
Q34300881Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.
Q34248040Immunosuppressive effect of cyclosporine metabolites from human bile on alloreactive T cells
Q73916473Impact of HLA-C on acute rejection in liver transplantation
Q37435542Laboratory monitoring of nonrenal allograft rejection.
Q73287861Mechanism of liver allograft rejection: the indirect recognition pathway
Q34275365New approaches in the use of cyclosporine: with particular reference to the liver.
Q34312217Pathologic analysis of liver transplantation for primary biliary cirrhosis
Q87258941Protein F-induced immune tolerance in liver transplantation in rats
Q36335800T-cell cloning in human type I diabetes
Q41575489The immunological role of biliary epithelial cells in human liver transplant rejection